Welcome to LookChem.com Sign In|Join Free

CAS

  • or

95899-01-7

(2-methoxyphenyl)(pyridine-2-yl)methanamine is a chemical compound with a molecular formula C13H13NO. It is a derivative of methanamine and contains a methoxyphenyl group as well as a pyridine-2-yl group. (2-methoxyphenyl)(pyridine-2-yl)methanamine has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs due to its structural features. It may also have uses in organic synthesis and as a reagent in chemical reactions. The unique combination of functional groups in (2-methoxyphenyl)(pyridine-2-yl)methanamine makes it an interesting target for further study and potential applications in various scientific and industrial fields.

95899-01-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 95899-01-7 Structure

  • Basic information

    1. Product Name: (2-methoxyphenyl)(pyridine-2-yl)methanamine
    2. Synonyms: (2-methoxyphenyl)(pyridine-2-yl)methanamine
    3. CAS NO:95899-01-7
    4. Molecular Formula:
    5. Molecular Weight: 214.267
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 95899-01-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (2-methoxyphenyl)(pyridine-2-yl)methanamine(CAS DataBase Reference)
    10. NIST Chemistry Reference: (2-methoxyphenyl)(pyridine-2-yl)methanamine(95899-01-7)
    11. EPA Substance Registry System: (2-methoxyphenyl)(pyridine-2-yl)methanamine(95899-01-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 95899-01-7(Hazardous Substances Data)

95899-01-7 Usage

Uses

Used in Medicinal Chemistry:
(2-methoxyphenyl)(pyridine-2-yl)methanamine is used as a building block for the development of pharmaceutical drugs, leveraging its structural features to create new compounds with potential therapeutic effects.
Used in Organic Synthesis:
(2-methoxyphenyl)(pyridine-2-yl)methanamine is used as a reagent in organic synthesis, contributing to the formation of complex organic molecules for various applications.
Used in Chemical Reactions:
(2-methoxyphenyl)(pyridine-2-yl)methanamine is used as a reagent in chemical reactions, facilitating specific transformations and providing a means to achieve desired products in the synthesis of various compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 95899-01-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,8,9 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 95899-01:
(7*9)+(6*5)+(5*8)+(4*9)+(3*9)+(2*0)+(1*1)=197
197 % 10 = 7
So 95899-01-7 is a valid CAS Registry Number.

95899-01-7Relevant articles and documents

Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule Screening

Engen, Karin,Rosenstr?m, Ulrika,Axelsson, Hanna,Konda, Vivek,Dahllund, Leif,Otrocka, Magdalena,Sigmundsson, Kristmundur,Nikolaou, Alexandros,Vauquelin, Georges,Hallberg, Mathias,Jenmalm Jensen, Annika,Lundb?ck, Thomas,Larhed, Mats

, p. 180 - 193 (2016)

Intracerebroventricular injection of angiotensin IV, a ligand of insulin-regulated aminopeptidase (IRAP), has been shown to improve cognitive functions in several animal models. Consequently, IRAP is considered a potential target for treatment of cognitiv

DOPAMINE D2 RECEPTOR LIGANDS

-

Page/Page column 115; 117; 125; 126; 127, (2016/07/05)

The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity.

IMIDAZOPYRIDINE DERIVATIVES AS BSR-3 ANTAGONISTS

-

Page/Page column 13-14, (2010/02/13)

Compounds of the general formula (I): wherein X, Y, R and R’ are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the pre

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 95899-01-7